Inhibikase Therapeutics Inc. (IKT)
NASDAQ · Healthcare
Inhibikase Therapeutics Inc. Price to Book Ratio 2020–2026
Price to book (P/B) ratio for Inhibikase Therapeutics Inc. (IKT): market cap divided by shareholder equity. As of March 31, 2026 it is 3.05.
From: 03/31/2021To: 03/31/2026
Stock Price
Book Value
Price to Book
Inhibikase Therapeutics Inc. Price to Book Ratio — FAQ
Inhibikase Therapeutics Inc. (IKT) price to book ratio over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IKT's price to book ratio history?
The chart and table above show Inhibikase Therapeutics Inc.'s price to book ratio by year and by quarter, including the growth rate.